Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Sep 30, 2019 11:12am

116 Views

Post# 30177650

RE:RE:Timeline

Canaccord is selling into the bids won't let it go higher most likely have shorted the stock no wonder they earned the name canacrap.

goldn1 wrote

Cancer free patient and very little buying... TLT needs to figure out how to get the word out... Unless your on sotckhouse, no one knows...

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario